Skip to content

13F-HR filed by Lagoda Investment Management, L.P.

Lagoda Investment Management, L.P. filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-15, with 36 holding rows worth $257,675,000.

Accession
0000905718-17-000563
Filed
2017-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2017

A holdings report, 36 entries on the cover page, a total value of $257,675,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $257,675,000 with VALUE read as thousands by filing date, 13F file number 028-16753. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
RENAISSANCERE HLDGS LTD COMG7496G103Stock185,840$26,882,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock69,133$26,790,000thousands by filing date
SEATTLE GENETICS INC812578102COM394,090$24,772,000thousands by filing date
PTC INC COM69370C100Stock459,627$24,153,000thousands by filing date
UBIQUITI NETWORKS INC90347A100COM422,129$21,216,000thousands by filing date
Alphabet Inc. Reg. Shares C02079K107COM23,937$19,857,000thousands by filing date
MONSANTO CO NEW61166W101COM158,879$17,985,000thousands by filing date
DIGIMARC CORP NEW COM25381B101COM608,493$16,429,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM117,945$14,300,000thousands by filing date
NOVO-NORDISK A S ADR670100205ADR399,013$13,678,000thousands by filing date
VOLITIONRX LTD928661107COM2,939,079$11,815,000thousands by filing date
TTOO89853L104Stock1,711,584$9,003,000thousands by filing date
Alphabet Inc. Reg. Shares A02079K305COM10,335$8,762,000thousands by filing date
INTREXON CORP46122T102COM415,890$8,243,000thousands by filing date
ENSTAR GROUP LIMITEDG3075P101SHS18,820$3,600,000thousands by filing date
TEXAS882610108COMMON STOCK9,336$2,612,000thousands by filing date
MERRIMACK PHARMACEUTICALS IN590328100COM775,571$2,389,000thousands by filing date
SENOMYX INC81724Q107COM2,391,308$2,369,000thousands by filing date
BERKSHIRE HATHAWAY INC DEL084670108CL A2$500,000thousands by filing date
Microsoft Corp594918104COM5,820$383,000thousands by filing date
Berkshire Hathaway Inc084670702COM2,235$373,000thousands by filing date
ALLEGHANY CORP DEL017175100COM455$280,000thousands by filing date
MasterCard, Inc57636Q104COM1,785$201,000thousands by filing date
BROWN FORMAN CORP CL B115637209Stock4,208$194,000thousands by filing date
EXXON MOBIL CORP30231G102COM2,215$182,000thousands by filing date
Coca-Cola Company191216100COM3,950$168,000thousands by filing date
Johnson & Johnson478160104COM900$112,000thousands by filing date
SPDR GOLD TR78463V107GOLD SHS900$107,000thousands by filing date
LAS VEGAS SANDS CORP COM517834107Stock1,350$77,000thousands by filing date
Procter & Gamble Co742718109COM690$62,000thousands by filing date
ConocoPhillips20825C104COM1,231$61,000thousands by filing date
Pfizer Inc.717081103COM1,226$42,000thousands by filing date
AQUABOUNTY TECHNOLOGIES INC03842K200COM NEW2,006$22,000thousands by filing date
AbbVie,Inc.00287Y109COM326$21,000thousands by filing date
Abbott Laboratories002824100COM426$19,000thousands by filing date
PHILLIPS 66 COM718546104Stock197$16,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000905718-17-000563this filing2017-05-15acceptance time not in the bulk data set